• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于高通量药物筛选的胶质母细胞瘤球体的快速且可重复生成。

Rapid and reproducible generation of glioblastoma spheroids for high-throughput drug screening.

作者信息

Bach Christian, Glasow Annegret, Baran-Schmidt Rainer, Oppermann Henry, Bach Christoph, Meixensberger Jürgen, Güresir Erdem, Gaunitz Frank

机构信息

Department of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.

Department of Radiotherapy and Radiooncology, University of Leipzig, Leipzig, Germany.

出版信息

Front Bioeng Biotechnol. 2024 Dec 18;12:1471012. doi: 10.3389/fbioe.2024.1471012. eCollection 2024.

DOI:10.3389/fbioe.2024.1471012
PMID:39744592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11688379/
Abstract

Identifying new substances that could potentially be used for tumor therapy and the precise analysis of their spectrum of action requires models that are as similar as possible to the tumor present in the patient. Traditionally, two-dimensional (2D) cell cultures are used. However, these only resemble solid tumors to a limited extent. More realistic models, such as tissue cultures, which are invaluable for the final analysis of the effect of new substances, are unsuitable for high-throughput screening (HTS), such as substance library screening. Therefore, we addressed which parameters need to be optimized to produce 3D cultures suitable for HTS using established tumor cell lines and ultra-low attachment plates, and we tested which experimental parameters need to be considered. In our studies, we have focused on cell lines from gliomas. Gliomas are incurable tumors of the central nervous system and are the subject of intensive research. Our studies used ten glioma cell lines from which we generated spheroids using ultra-low attachment plates. We then determined the spheroid size as a function of the initial cell number and the culture time. We analyzed cell viability using propidium iodide staining, evaluated the effects of temozolomide and radiation on spheroids, and compared the effect to that on 2D cultures. We found that spheroid size correlated linearly with the initial cell number. Fewer cells (250-500) generally resulted in better growth than a higher number. However, not all cell lines produced growing spheroids at all. The spheroids had an outer layer of living cells and an inner core of dead cells. The size of the inner core of dead cells was different in the various cell lines and developed differently during the incubation period. Radiation affected spheroids more than 2D cultures, especially at higher cell densities. Our results provide insight into using glioma cell lines to form spheroids as model systems. We have identified initial cell numbers as a critical parameter for their effective use in research, offering a hopeful outlook for tumor therapy research and drug development.

摘要

识别可能用于肿瘤治疗的新物质并精确分析其作用谱,需要尽可能与患者体内肿瘤相似的模型。传统上,使用二维(2D)细胞培养。然而,这些仅在有限程度上类似于实体瘤。更现实的模型,如组织培养,虽然对新物质效果的最终分析非常有价值,但不适用于高通量筛选(HTS),如物质库筛选。因此,我们探讨了使用已建立的肿瘤细胞系和超低附着板产生适合HTS的3D培养物需要优化哪些参数,并测试了需要考虑哪些实验参数。在我们的研究中,我们专注于胶质瘤细胞系。胶质瘤是中枢神经系统的不治之症肿瘤,是深入研究的对象。我们的研究使用了十种胶质瘤细胞系,我们使用超低附着板从中生成球体。然后,我们确定球体大小作为初始细胞数量和培养时间的函数。我们使用碘化丙啶染色分析细胞活力,评估替莫唑胺和辐射对球体的影响,并将其与对2D培养物的影响进行比较。我们发现球体大小与初始细胞数量呈线性相关。细胞数量较少(250 - 500个)通常比数量较多时生长得更好。然而,并非所有细胞系都能产生生长的球体。球体有一层活细胞外层和一层死细胞内核。不同细胞系中死细胞内核的大小不同,并且在孵育期内发育方式也不同。辐射对球体的影响比对2D培养物的影响更大,尤其是在较高细胞密度时。我们的结果为使用胶质瘤细胞系形成球体作为模型系统提供了见解。我们已经确定初始细胞数量是其在研究中有效使用的关键参数,为肿瘤治疗研究和药物开发提供了充满希望的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/82c2e9b15bda/fbioe-12-1471012-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/1b05ff6580b5/fbioe-12-1471012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/065870cae2e3/fbioe-12-1471012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/709eabb0e389/fbioe-12-1471012-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/812fd8e4c29f/fbioe-12-1471012-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/650ba87b365a/fbioe-12-1471012-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/39bb179463fa/fbioe-12-1471012-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/82c2e9b15bda/fbioe-12-1471012-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/1b05ff6580b5/fbioe-12-1471012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/065870cae2e3/fbioe-12-1471012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/709eabb0e389/fbioe-12-1471012-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/812fd8e4c29f/fbioe-12-1471012-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/650ba87b365a/fbioe-12-1471012-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/39bb179463fa/fbioe-12-1471012-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/486e/11688379/82c2e9b15bda/fbioe-12-1471012-g007.jpg

相似文献

1
Rapid and reproducible generation of glioblastoma spheroids for high-throughput drug screening.用于高通量药物筛选的胶质母细胞瘤球体的快速且可重复生成。
Front Bioeng Biotechnol. 2024 Dec 18;12:1471012. doi: 10.3389/fbioe.2024.1471012. eCollection 2024.
2
Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research?患者来源球体培养模型在软骨肉瘤研究中有相关性吗?
Clin Orthop Relat Res. 2021 Mar 1;479(3):477-490. doi: 10.1097/CORR.0000000000001317.
3
Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres.多重检测球体体积、刃天青和酸性磷酸酶活力测定法用于肿瘤球体和干细胞神经球的高通量筛选
PLoS One. 2014 Aug 13;9(8):e103817. doi: 10.1371/journal.pone.0103817. eCollection 2014.
4
High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.在384孔超低附着板中生成的头颈部鳞状细胞癌多细胞肿瘤球体培养物的高内涵筛选表征,以筛选更好的癌症药物先导物。
Assay Drug Dev Technol. 2019 Jan;17(1):17-36. doi: 10.1089/adt.2018.896. Epub 2018 Dec 28.
5
Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.勘误:利用幼苗浸没法高通量鉴定番茄对丁香假单胞菌 pv.番茄的抗性。
J Vis Exp. 2023 Oct 18(200). doi: 10.3791/6576.
6
Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.均匀性胰腺癌球体模拟循环肿瘤细胞簇和大转移灶的生长模式:在内层呈现异质性和火山口样结构。
J Cancer Res Clin Oncol. 2017 Sep;143(9):1771-1786. doi: 10.1007/s00432-017-2434-2. Epub 2017 May 11.
7
Development of 3D cultures of zebrafish liver and embryo cell lines: a comparison of different spheroid formation methods.建立斑马鱼胚胎细胞系和肝脏 3D 培养物:不同球体形成方法的比较。
Ecotoxicology. 2021 Nov;30(9):1893-1909. doi: 10.1007/s10646-021-02459-6. Epub 2021 Aug 11.
8
Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements.技术报告:液体覆盖技术可生成均匀的骨肉瘤、胶质母细胞瘤、肺癌和前列腺腺癌球体,可用于药物细胞毒性测量。
Front Bioeng Biotechnol. 2023 Oct 6;11:1260049. doi: 10.3389/fbioe.2023.1260049. eCollection 2023.
9
MTS, WST-8, and ATP viability assays in 2D and 3D cultures: Comparison of methodologically different assays in primary human chondrocytes.二维和三维培养物中的 MTS、WST-8 和 ATP 生存能力测定:原代人软骨细胞中方法学不同测定法的比较。
Clin Hemorheol Microcirc. 2024;88(s1):S3-S19. doi: 10.3233/CH-248101.
10
RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.单细胞和多细胞类型肿瘤球体的 RNAi 高通量筛选:二维和三维的综合分析。
SLAS Discov. 2017 Jun;22(5):525-536. doi: 10.1177/2472555217696796. Epub 2017 Mar 9.

本文引用的文献

1
Methods in cancer research: Assessing therapy response of spheroid cultures by life cell imaging using a cost-effective live-dead staining protocol.癌症研究方法:使用具有成本效益的活死染色方案通过活细胞成像评估球体培养物的治疗反应。
Biol Methods Protoc. 2024 Aug 22;9(1):bpae060. doi: 10.1093/biomethods/bpae060. eCollection 2024.
2
Development of a 3D Tumor Spheroid Model from the Patient's Glioblastoma Cells and Its Study by Metabolic Fluorescence Lifetime Imaging.从患者的脑胶质瘤细胞中开发三维肿瘤球体模型及其代谢荧光寿命成像研究。
Sovrem Tekhnologii Med. 2023;15(2):28-38. doi: 10.17691/stm2023.15.2.03. Epub 2023 Mar 29.
3
Robust formation of optimal single spheroids towards cost-effective in vitro three-dimensional tumor models.
稳健形成最优的单一球体以实现具有成本效益的体外三维肿瘤模型。
FEBS Open Bio. 2023 Jul;13(7):1266-1277. doi: 10.1002/2211-5463.13614. Epub 2023 May 5.
4
A mechanobiological model for tumor spheroid evolution with application to glioblastoma: A continuum multiphysics approach.具有脑胶质瘤应用的肿瘤球体演变的机械生物力学模型:连续体多物理方法。
Comput Biol Med. 2023 Jun;159:106897. doi: 10.1016/j.compbiomed.2023.106897. Epub 2023 Apr 18.
5
Three-Dimensional (3D) in vitro cell culture protocols to enhance glioblastoma research.三维(3D)体外细胞培养方案以增强脑胶质瘤研究。
PLoS One. 2023 Feb 8;18(2):e0276248. doi: 10.1371/journal.pone.0276248. eCollection 2023.
6
A high-density 3-dimensional culture model of human glioblastoma for rapid screening of therapeutic resistance.一种用于快速筛选治疗耐药性的人胶质母细胞瘤高密度三维培养模型。
Biochem Pharmacol. 2023 Feb;208:115410. doi: 10.1016/j.bcp.2023.115410. Epub 2023 Jan 9.
7
Advanced Cellular Models for Preclinical Drug Testing: From 2D Cultures to Organ-on-a-Chip Technology.用于临床前药物测试的先进细胞模型:从二维培养到芯片器官技术
Cancers (Basel). 2022 Jul 28;14(15):3692. doi: 10.3390/cancers14153692.
8
Why 90% of clinical drug development fails and how to improve it?为什么90%的临床药物研发会失败以及如何改进?
Acta Pharm Sin B. 2022 Jul;12(7):3049-3062. doi: 10.1016/j.apsb.2022.02.002. Epub 2022 Feb 11.
9
Survival Outcomes and Prognostic Factors in Glioblastoma.胶质母细胞瘤的生存结果与预后因素
Cancers (Basel). 2022 Jun 28;14(13):3161. doi: 10.3390/cancers14133161.
10
Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.肿瘤球体细胞系中分子改变和药物反应谱的纵向稳定性可实现可重复的分析。
Biomed Pharmacother. 2021 Dec;144:112278. doi: 10.1016/j.biopha.2021.112278. Epub 2021 Oct 7.